Lisa Clarke, Executive Director, Destination Medical Center Economic Development Agency (Q4 2020)
Venture capital groups are raising money to invest in U.S.- based infrastructure for large-scale bio-therapy manufacturing, the need for which was highlighted by the COVID-19 pandemic.More
Darren Jones, John Finan, and Cory Wendt, Baker Tilly US, LLP (Q4 2020)
With global vulnerabilities in the supply chain and the ever-changing landscape of the “new normal,” pharma industry leaders need to have a clear map for the road ahead.More
If necessity is the mother of invention, the COVID-19 crisis is driving cooperative innovation by companies, government entities, and healthcare organizations. More
Lisa Clarke, Executive Director, Destination Medical Center Economic Development Agency (Q2 2020)
Lisa Clarke, Executive Director, Destination Medical Center Economic Development Agency, spoke with Area Development about the largest public-private economic initiative in Minnesota’s history, at our Women in Economic Development Consultants Forum.More
Steve Kaelble, Staff Editor, Area Development (Q2 2019)
Both domestic and foreign advanced technology and other firms are investing in Indiana, a state with a well-prepared workforce and
lifestyle initiatives to attract younger workers.
More
Roger Humphrey, Division President, Industries, JLL (Q4 2018)
Life sciences companies are seeking locations where they can attract top talent and identify flexible facilities, which is directly affecting their real estate decisions.More
Mark Crawford, Staff Editor, Area Development (Q2 2018)
The success of Orlando’s theme park industry and cross-disciplinary technology innovation have led to the region becoming a leading destination for high-tech companies. More
Dan Emerson, Staff Editor, Area Development (Q1 2017)
Funding provided by the 21st Century Cures Act, as well changes in FDA approval procedures, may lead pharma and medical device companies to expand their operations, with an eye on U.S. locations to accommodate the new administration’s interventions.More
Woody Hydrick, Managing Principal, Global Location Strategies (Directory 2017)
A pharma company’s position in the drug life cycle chain affects where it will locate, as does its need for a skilled workforce and low taxes, among other concerns. More
Dale D. Buss, Staff Editor, Area Development (Q2 2016)
Through industrial diversification, Texas has been able to overcome a decline in economic output resulting from lower oil prices and continues to court companies with its pro-business know-how.More
Mark Crawford, Staff Editor, Area Development (Q1 2016)
Mike Molnar, Director of the U.S. Department of Commerce’s Advanced Manufacturing Office, based at the National Institute of Standards and Technology, describes what’s being done to maintain U.S. leadership in this arena.More
Karen Thuermer, Staff Editor, Area Development (Q2 2015)
Bioresearch got a shot in the arm when the National Institutes of Health announced that three proof-of-concept hubs would join three already existing Research Evaluation and Commercialization Hubs: The Long Island Bioscience Hub, The University of Louisville and The University of Minnesota.More
Adams Nager, Economic Research Assistant, Information Technology and Innovation Foundation (Q1 2015)
Adams Nager, an economic research assistant at the Information Technology and Innovation Foundation, recently talked with Area Development about the state of manufacturing in the U.S. In his career, Nager has focused on macroeconomic growth, competitiveness, and tax theory.More
Karen Thuermer, Staff Editor, Area Development (Directory 2015)
In the Wizard of Oz, Dorothy’s Kansas home is blown away by a powerful tornado. Today, this prairie state is harnessing its wind power for economic development gain. And, the generally low tax environment and plentiful incentives are encouraging investment in renewable energy, life sciences, other R&D throughout all of the plains states.More
Craig Guillot, Staff Editor, Area Development (Directory 2015)
As New Orleans approaches the 10-year anniversary of Hurricane Katrina in 2015, the city is in many ways barely recognizable to what it was years ago. Economists and national publications say it has undergone one of the most rapid and dramatic economic turnarounds in recent American history.More
Mark Crawford, Staff Editor, Area Development (Q4 2014)
U.S. manufacturers are investing in advanced equipment, automation, and robotics in order to drive down the cost of production and compete in the global economy. The net result has the potential to transform our industrial base.More
Mark Crawford, Staff Editor, Area Development (Q4 2014)
Major economic, social, and regulatory factors are having big impacts on the life sciences and medical device industries, representing an opportunity for innovative companies to become new leaders and gain market share.More
Mark Crawford, Staff Editor, Area Development (Q3 2014)
These interconnected industries will be drivers in stimulating economic growth, creating jobs, and improving global competitiveness. Collaboration among private-sector companies, universities, and government on research and commercialization will be vital. More
Mark Crawford, Staff Editor, Area Development (Location Canada 2014)
A leader in innovative manufacturing, Canada recognizes and supports its knowledge-based, high-tech industries which, in turn, continue to invest in cutting-edge R&DMore